These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11474882)

  • 1. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine differentiation in prostatic malignancy.
    di Sant'Agnese PA; Cockett AT
    Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small cell carcinoma of the prostate: a case report].
    Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
    Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
    Matsumoto Y; Mibu H; Kagebayashi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of prostatic small cell carcinoma].
    Hashimoto Y; Kimura G; Tsuboi N; Akimoto M
    Hinyokika Kiyo; 2000 Jun; 46(6):425-7. PubMed ID: 10934615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H
    Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
    Miyoshi Y; Inoue Y; Matsuzaki J; Fukuda M; Satomi Y; Akahane H; Saito S
    Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
    Sciarra A; Cardi A; Dattilo C; Mariotti G; Di Monaco F; Di Silverio F
    Int J Clin Pract; 2006 Apr; 60(4):462-70. PubMed ID: 16620361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
    Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
    Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual prostate carcinoma characterized by extensive metastasis, significantly increased serum level of prostatic-specific antigen,and neuroendocrine differentiation: a case report.
    Hu YX; Ye J; Jiang Y; Zhang QF; Wu YL; Chen YY
    Chin Med J (Engl); 2005 Feb; 118(3):258-61. PubMed ID: 15740661
    [No Abstract]   [Full Text] [Related]  

  • 19. Divergent neuroendocrine differentiation in prostatic carcinoma.
    di Sant' Agnese PA
    Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of histological types of prostatic cancer].
    Medvedev VL; Matsionis AE; Medvedeva LA
    Urologiia; 2003; (6):10-4. PubMed ID: 14708236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.